Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1976-8-2
|
pubmed:abstractText |
Tissue fibrinolytic activity, mainly due to activator of tissue plasminogen was increased in the biopsied gastric mucosa of patients with protein-losing gastropathy. Antiplasmin therapy with trans-AMCHA (trans-4-aminomethyl cyclohexane carboxylic acid) was dramatically effective, except in the case of a patient with intestinal lymphangiectasia. These findings suggest that increased fibrinolysis in the gastrointestinal mucosa may play an important role in enhancing mucosal permeability to plasma proteins.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0016-5085
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1045-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1269863-Adult,
pubmed-meshheading:1269863-Fibrinolysis,
pubmed-meshheading:1269863-Gastric Mucosa,
pubmed-meshheading:1269863-Humans,
pubmed-meshheading:1269863-Male,
pubmed-meshheading:1269863-Plasminogen Activators,
pubmed-meshheading:1269863-Protein-Losing Enteropathies,
pubmed-meshheading:1269863-Tranexamic Acid
|
pubmed:year |
1976
|
pubmed:articleTitle |
Tissue plasminogen activator in the pathogenesis of protein-losing gastroenteropathy.
|
pubmed:publicationType |
Journal Article,
Case Reports
|